Position in OMER
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$37,587,506
-$21,661,142 QoQ
Shares Held
3,559,423
+3.2% QoQ
Ownership
4.92%
of shares outstanding
% of Portfolio
1.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2.30492414079473.ToString("F0")%
Shared 0.ToString("F0")%
None 97.69507585920528.ToString("F0")%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Derivatives in OMER
reported options exposure · as of Sep 30, 2025CallValue
$176,300
CallShares
43,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026INGALLS & SNYDER LLC holds $352,579,823 across 11 Biotechnology names. OMER ranks #2 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
7,608,716 | $306,707,341 | |
| 2 | OMER |
Omeros Corp
This page
|
3,559,423 | $37,587,506 | |
| 3 | HYFT |
MindWalk Holdings Corp.
|
2,907,040 | $3,284,955 | |
| 4 | GMAB |
Genmab A/S
|
72,891 | $1,955,665 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,012 | $1,344,978 | |
| 6 | EPRX |
Eupraxia Pharmaceuticals Inc.
|
75,650 | $547,706 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
7,339 | $474,319 | |
| 8 | VCEL |
Vericel Corp
|
14,200 | $456,814 |
All Filings in OMER
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,587,506 | 3,559,423 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $59,248,648 | 3,448,699 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $176,300 | 43,000 | Call | Other | 2025-11-07 | |
| 2025-09-30 | $16,837,051 | 4,106,598 | Shares | Other | 2025-11-07 | |
| 2025-06-30 | $11,948,739 | 3,982,913 | Shares | Other | 2025-07-31 | |
| 2025-03-31 | $32,697,622 | 3,977,813 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $39,597,735 | 4,007,868 | Shares | Other | 2025-01-29 | |
| 2024-12-31 | $41,113,792 | 4,161,315 | Shares | Sole | 2025-02-21 | |
| 2024-09-30 | $18,021,477 | 4,539,415 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $18,648,180 | 4,593,148 | Shares | Other | 2024-07-31 | |
| 2024-03-31 | $16,208,583 | 4,698,140 | Shares | Other | 2024-05-13 | |
| 2023-12-31 | $14,867,911 | 4,546,762 | Shares | Other | 2024-01-29 | |
| 2023-12-31 | $32,700 | 10,000 | Call | Other | 2024-01-29 | |
| 2023-09-30 | $87,600 | 30,000 | Call | Other | 2023-11-02 | |
| 2023-09-30 | $13,559,271 | 4,643,586 | Shares | Other | 2023-11-02 | |
| 2023-06-30 | $25,330,059 | 4,656,261 | Shares | Other | 2023-07-27 | |
| 2023-03-31 | $11,625 | 2,500 | Call | Other | 2023-05-09 | |
| 2023-03-31 | $21,685,465 | 4,663,541 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $8,332,034 | 3,686,741 | Shares | Other | 2023-01-31 | |
| 2022-09-30 | $12,888,552 | 4,091,604 | Shares | Other | 2022-10-21 | |
| 2022-06-30 | $11,414,595 | 4,150,762 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $25,272,590 | 4,205,090 | Shares | Other | 2022-05-09 | |
| 2021-12-31 | $116,383 | 18,100 | Call | Other | 2022-02-11 | |
| 2021-12-31 | $27,798,349 | 4,323,227 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $61,538,109 | 4,462,517 | Shares | Other | 2021-10-27 | |
| 2021-06-30 | $66,328,374 | 4,469,567 | Shares | Other | 2021-08-03 | |
| 2021-03-31 | $76,892,297 | 4,319,792 | Shares | Other | 2021-04-21 | |
| 2020-12-31 | $62,393,326 | 4,366,223 | Shares | Other | 2021-01-27 | |
| 2020-09-30 | $44,614,702 | 4,412,928 | Shares | Other | 2020-10-21 | |
| 2020-06-30 | $65,321,000 | 4,437,568 | Shares | Other | 2020-07-31 | |
| 2020-03-31 | $61,987,397 | 4,636,305 | Shares | Other | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||